| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |